High Efficacy of Sofosbuvir/Velpatasvir and Impact of Baseline Resistance-Associated Substitutions in Hepatitis C Genotype 3 Infection

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14592
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial

Gastroenterology
HepatologyGastroenterology
2016English

Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia

American Journal of Hematology
Hematology
2018English

Prevalence of Resistance Associated Substitutions and Efficacy of Baseline Resistance-Guided Chronic Hepatitis C Treatment in Spain From the GEHEP-004 Cohort

PLoS ONE
Multidisciplinary
2019English

NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection

Hepatology
MedicineHepatology
2018English

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections

Gastroenterology
HepatologyGastroenterology
2016English

Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus

Hepatology
MedicineHepatology
2017English

Baseline Hepatitis C Virus Resistance-Associated Substitutions Present at Frequencies Lower Than 15% May Be Clinically Significant

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology
HepatologyGastroenterology
2019English

Efficacy and Safety of Generic Daclatasvir + Sofosbuvir ± Ribavirin in Treatment of Genotype 3 Infected Hepatitis C Patients - A Real Life Experience From Pakistan

Hepatoma Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy